SCNX Scienture Holdings, Inc.

Nasdaq scienture.com


$ 0.51 $ -0.05 (-9.29 %)    

Friday, 17-Oct-2025 19:55:43 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 0.5351
$ 0.55
$ 0.50 x 500
$ 0.62 x 10,000
$ 0.52 - $ 0.57
$ 0.52 - $ 9.55
3,547,579
na
8.63M
$ 2.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-26-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 06-26-2024 03-31-2024 10-Q
7 04-22-2024 12-31-2023 10-K
8 01-16-2024 09-30-2023 10-Q
9 08-18-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-27-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 07-25-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-28-2022 12-31-2021 10-K
16 10-25-2021 09-30-2021 10-Q
17 07-26-2021 06-30-2021 10-Q
18 04-26-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
20 10-26-2020 09-30-2020 10-Q
21 07-27-2020 06-30-2020 10-Q
22 05-04-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 10-28-2019 09-30-2019 10-Q
25 07-26-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-22-2019 12-31-2018 10-K
28 10-26-2018 09-30-2018 10-Q
29 07-27-2018 06-30-2018 10-Q
30 04-27-2018 03-31-2018 10-Q
31 03-02-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-30-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 04-20-2016 03-31-2016 10-Q
39 03-28-2016 12-31-2015 10-K
40 11-02-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets...

Core News & Articles

SCIENTURE HOLDINGS, INC. ( SCNX), a holding company for existing and planned pharmaceutical operating companies focused on prov...

Core News & Articles

-SEC Filing

Core News & Articles

SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused o...

Core News & Articles

Scienture Holdings (NASDAQ:SCNX) reported quarterly losses of $(0.48) per share. This is a 58.62 percent increase over losses o...

Core News & Articles

-SEC Filing

Core News & Articles

Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company") a holding company...

Core News & Articles

SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company"), a holding company for existing and planned pharmaceutical opera...

Core News & Articles

SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused o...

Core News & Articles

AMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) a holding company for existing and planned ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION